Rocket Pharmaceuticals Inc (RCKT)

$3.00 -0.33 (-9.91%)
Market Cap 360.38M
Revenue (ttm) 0.00
Net Income (ttm) -258.75M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 3,078,300
Avg Vol 2,034,458
Day's Range N/A - N/A
Shares Out 108.22M
Stochastic %K 0%
Beta 0.48
Analysts Sell
Price Target $7.65

Company Profile

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States. It develops vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure (RP-A501), which is in Phase 2 trial; Plakophilin-2 Arrhythmogenic Cardiomyopathy (PKP2-ACM), an inher...

Industry: Biotechnology
Sector: Healthcare
Phone: 609 659 8001
Address:
9 Cedarbrook Drive, Cranbury, United States
Bellz22
Bellz22 Feb. 6 at 2:18 AM
$RCKT
0 · Reply
JoshThe3rd
JoshThe3rd Feb. 5 at 11:34 PM
$RCKT bagholding, but I still believe the story is salvageable. Just got to ride out the normal XBI sell offs.
0 · Reply
xXCronoSXx
xXCronoSXx Feb. 5 at 8:45 PM
$RCKT well i am aplying to Mcdonald. :+(
0 · Reply
JunkPost
JunkPost Feb. 5 at 8:30 PM
$RCKT $2.81 must hold
0 · Reply
SinglesOverHomeRun
SinglesOverHomeRun Feb. 5 at 8:01 PM
$RCKT putting my tax refund here 🤑
0 · Reply
Bellz22
Bellz22 Feb. 5 at 5:10 PM
$RCKT
0 · Reply
buymoremakemore
buymoremakemore Feb. 5 at 4:57 PM
$RCKT This is my last post before watching this lift back off. I moved some things around. I now have 50,000 shares. $22,000 net house surplus . RCKT is really going to have to trade sideways from here for that padding to dissipate. See you guys at $4 in a few weeks.
2 · Reply
Stockseeking
Stockseeking Feb. 5 at 4:48 PM
$RCKT Not happy with the price. Nothing specific to RCKT. Too bad no dry powder. Sp will come back for sure leading to PDUFA and after approval.
0 · Reply
Plowmaster
Plowmaster Feb. 5 at 4:45 PM
$RCKT loading zone!
0 · Reply
buymoremakemore
buymoremakemore Feb. 5 at 4:13 PM
$RCKT Bought another 10k shares the last 2 days. Next week we flush out this overdone selling.
0 · Reply
Latest News on RCKT
Rocket Pharmaceuticals, Inc. (RCKT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 14, 2026, 5:16 PM EST - 22 days ago

Rocket Pharmaceuticals, Inc. (RCKT) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Jan 5, 2026, 7:00 AM EST - 4 weeks ago

Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Rocket Pharmaceuticals: Deep Dislocation Offers Asymmetric Upside On LAD-I Approval And Amended Danon Program

Dec 26, 2025, 10:23 AM EST - 5 weeks ago

Rocket Pharmaceuticals: Deep Dislocation Offers Asymmetric Upside On LAD-I Approval And Amended Danon Program

Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference

Nov 25, 2025, 7:00 AM EST - 2 months ago

Rocket Pharmaceuticals to Participate in the 8th Annual Evercore Healthcare Conference

Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

Nov 6, 2025, 4:00 PM EST - 3 months ago

Rocket Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Progress

FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy Application Reestablishes Momentum For Stock

Oct 14, 2025, 2:27 PM EDT - 4 months ago

FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy Application Reestablishes Momentum For Stock

Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)

Oct 14, 2025, 7:00 AM EDT - 4 months ago

Rocket Pharmaceuticals Announces FDA Acceptance of BLA Resubmission of KRESLADI™ for the Treatment of Severe Leukocyte Adhesion Deficiency-I (LAD-I)

Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Oct 10, 2025, 4:00 PM EDT - 4 months ago

Rocket Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Rocket Pharmaceuticals withdraws US application of gene therapy for rare blood disorder

Oct 3, 2025, 7:11 AM EDT - 4 months ago

Rocket Pharmaceuticals withdraws US application of gene therapy for rare blood disorder

Rocket Pharmaceuticals, Inc. (RCKT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 9, 2025, 12:36 PM EDT - 5 months ago

Rocket Pharmaceuticals, Inc. (RCKT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences

Aug 28, 2025, 7:00 AM EDT - 5 months ago

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences

Gene Therapy Trial Can Restart After Patient Death, FDA Says. The Sector Remains Depressed.

Aug 20, 2025, 11:02 AM EDT - 6 months ago

Gene Therapy Trial Can Restart After Patient Death, FDA Says. The Sector Remains Depressed.

FDA Lifts Rocket Pharmaceuticals Study Hold For Rare Disease Gene Therapy

Aug 20, 2025, 9:31 AM EDT - 6 months ago

FDA Lifts Rocket Pharmaceuticals Study Hold For Rare Disease Gene Therapy

US FDA lifts clinical hold on Rocket Pharmaceuticals' gene therapy trial

Aug 20, 2025, 7:09 AM EDT - 6 months ago

US FDA lifts clinical hold on Rocket Pharmaceuticals' gene therapy trial

Rocket Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on the Pivotal Phase 2 Trial of RP-A501 for the Treatment of Danon Disease

Aug 20, 2025, 7:00 AM EDT - 6 months ago

Rocket Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on the Pivotal Phase 2 Trial of RP-A501 for the Treatment of Danon Disease

DEADLINE NEXT WEEK: Berger Montague Advises Rocket Pharmaceuticals (NASDAQ: RCKT) Investors to Contact the Firm Before August 11, 2025

Aug 8, 2025, 2:16 PM EDT - 6 months ago

DEADLINE NEXT WEEK: Berger Montague Advises Rocket Pharmaceuticals (NASDAQ: RCKT) Investors to Contact the Firm Before August 11, 2025

Rocket Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Progress

Aug 7, 2025, 4:00 PM EDT - 6 months ago

Rocket Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Progress

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 30, 2025, 6:29 PM EDT - 6 months ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?

Jul 30, 2025, 11:07 AM EDT - 6 months ago

What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?

CAPR SRPT CABA NGNE NTLA QURE

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 29, 2025, 10:26 AM EDT - 6 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Rocket Refocuses Pipeline As Gene Therapy Sentiment Sours

Jul 25, 2025, 3:02 PM EDT - 6 months ago

Rocket Refocuses Pipeline As Gene Therapy Sentiment Sours

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Pharmaceuticals, Inc. Lawsuit – RCKT

Jul 24, 2025, 4:02 PM EDT - 7 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Pharmaceuticals, Inc. Lawsuit – RCKT

Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs

Jul 24, 2025, 7:00 AM EDT - 7 months ago

Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs

Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A601 Gene Therapy for PKP2-Arrhythmogenic Cardiomyopathy

Jul 17, 2025, 7:00 AM EDT - 7 months ago

Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A601 Gene Therapy for PKP2-Arrhythmogenic Cardiomyopathy

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 11, 2025, 10:25 AM EDT - 7 months ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Safety Disclosures and Stock Drop

Jul 9, 2025, 5:16 PM EDT - 7 months ago

Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Safety Disclosures and Stock Drop

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Lawsuit - RCKT

Jul 7, 2025, 9:00 AM EDT - 7 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Lawsuit - RCKT

Rocket Pharmaceuticals Announces FDA IND Clearance of RP-A701 for the Treatment of BAG3-associated Dilated Cardiomyopathy

Jun 30, 2025, 7:00 AM EDT - 7 months ago

Rocket Pharmaceuticals Announces FDA IND Clearance of RP-A701 for the Treatment of BAG3-associated Dilated Cardiomyopathy

Bellz22
Bellz22 Feb. 6 at 2:18 AM
$RCKT
0 · Reply
JoshThe3rd
JoshThe3rd Feb. 5 at 11:34 PM
$RCKT bagholding, but I still believe the story is salvageable. Just got to ride out the normal XBI sell offs.
0 · Reply
xXCronoSXx
xXCronoSXx Feb. 5 at 8:45 PM
$RCKT well i am aplying to Mcdonald. :+(
0 · Reply
JunkPost
JunkPost Feb. 5 at 8:30 PM
$RCKT $2.81 must hold
0 · Reply
SinglesOverHomeRun
SinglesOverHomeRun Feb. 5 at 8:01 PM
$RCKT putting my tax refund here 🤑
0 · Reply
Bellz22
Bellz22 Feb. 5 at 5:10 PM
$RCKT
0 · Reply
buymoremakemore
buymoremakemore Feb. 5 at 4:57 PM
$RCKT This is my last post before watching this lift back off. I moved some things around. I now have 50,000 shares. $22,000 net house surplus . RCKT is really going to have to trade sideways from here for that padding to dissipate. See you guys at $4 in a few weeks.
2 · Reply
Stockseeking
Stockseeking Feb. 5 at 4:48 PM
$RCKT Not happy with the price. Nothing specific to RCKT. Too bad no dry powder. Sp will come back for sure leading to PDUFA and after approval.
0 · Reply
Plowmaster
Plowmaster Feb. 5 at 4:45 PM
$RCKT loading zone!
0 · Reply
buymoremakemore
buymoremakemore Feb. 5 at 4:13 PM
$RCKT Bought another 10k shares the last 2 days. Next week we flush out this overdone selling.
0 · Reply
buymoremakemore
buymoremakemore Feb. 5 at 3:05 PM
$RCKT This is insanity. Fuck you shorts
2 · Reply
Stockseeking
Stockseeking Feb. 5 at 11:54 AM
$RCKT less than 2 months to potential approval. CRL is due to CMC issues. Approval is >90%.
0 · Reply
BOUDIN420
BOUDIN420 Feb. 5 at 4:45 AM
$RCKT
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 5 at 3:05 AM
$RCKT Current Stock Price: $3.33 Contracts to trade: $2.5 RCKT Feb 20 2026 Call Entry: $0.55 Exit: $1.04 ROI: 90% Hold ~25 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
1 · Reply
buymoremakemore
buymoremakemore Feb. 4 at 10:58 PM
$RCKT uptrend again soon. Hope people are buying the dip.
0 · Reply
Willdowdell
Willdowdell Feb. 4 at 6:08 PM
$RCKT this makes no sense.
1 · Reply
buymoremakemore
buymoremakemore Feb. 4 at 6:07 PM
$RCKT just bought another 5k shares
0 · Reply
buymoremakemore
buymoremakemore Feb. 4 at 6:00 PM
$RCKT i got 40k shares at $3.68. This dip is a gift
2 · Reply
bonghulk
bonghulk Feb. 4 at 5:51 PM
$RCKT OI is continuing to rise. Buyers are coming in
0 · Reply
psw_psw
psw_psw Feb. 4 at 5:42 PM
$RCKT sincerely, from Italy, i don't understand American's trader. This company has 94,2% institutionals, 3,64% insiders. Only 2% retails. So, what are you waiting for? Tell me, please.
2 · Reply
janed102
janed102 Feb. 4 at 4:14 PM
$RCKT only 16% short float, does not really worry me.
0 · Reply
janed102
janed102 Feb. 4 at 3:45 PM
$RCKT What's the options looking like??
0 · Reply